NRNP 6675 Final Exam (2 Versions, 200 Q & A, Latest-2022/2023) / NRNP 6675N Final Exam / NRNP6675 Final Exam / NRNP-6675N Final Exam

NRNP 6675 Midterm 2023 Exam-457 Questions with Updated Answers

NRNP 6675 Final Exam Test Questions with 100% Verified Answers

NRNP 6675 week 11 final Exam with 100% Verified and Updated Answers

1. Discrepancy between anatomical sex and gender is known as?: B) GenderDiscordance 2. Which of the following are risk factorsfor neuroleptic malignantsyndrome?Select all that apply: Rapid dose escalation;parental route of administration;higherpotency typical antipsychotics 3. Antipsychotic medication provides D2 blockage in the meso-coritcal path-way causing which of the following effects?: B) Increases EPS Incorrect: reduces negative s/s, causes prolactinemia, reduces positive symptoms 4...

NRNP 6675 Midterm Exam (100 Questions with Verified Answers)/NRNP 6675 Midterm Exam (100 Questions with Verified Answers)/NRNP 6675 Midterm Exam (100 Questions with Verified Answers)/NRNP 6675 Midterm Exam (100 Questions with Verified Answers)

NRNP 6675 MIDTERM EXAM NRNP6675 PSYCHIATRIC MENTAL HEALTH NURSE PRACTICTIONER CARE ACROSS THE LIFESPAN ii MIDTERM EXAM 2024 GRADED A+ LATEST GUIDE. 2 / 39 1. Discrepancy between anatomical sex and gender is known as?: B) GenderDiscordance 2. Which of the following are risk factorsfor neuroleptic malignantsyndrome?Select all that apply: Rapid dose escalation;parental route of administration;higherpotency typical antipsychotics 3. Antipsychotic medication provides D2 blockage in the mes...

1. Which of the following are risk factors for neuroleptic malignant syndrome? Select all that apply Age Rapid dose escalation Parental route of administration Higher potency typical antipsychotics 2. Antipsychotic medications provide D2 blockade in the mesocortical pathway causing which of the following effects? Reduces negative symptoms Increases extra pyramidal symptoms (EPS) Causes prolactinemia Reduces positive symptoms 3. Phencyclidine (PCP) and Ketamine exe...